Biblio Discovery — Demo Discovery Service

31,912 results

Showing 881–900 · 0.73 seconds · RSS

  1. Journal Article

    Crude Astragalus polysaccharides ameliorate cognitive impairment by preserving blood-brain barrier integrity and suppressing GSDMD-mediated pyroptosis in jellyfish-envenomed mice

    Zichong Yao; Ruxue Li; Ming Li et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    IntroductionJellyfish envenomation is an escalating global health threat that can induce severe neurotoxic consequences, but effective therapeutic strategies remain limited. This study investigated whether crude astragalus polysaccharides (APS) protect against jellyfish venom-induced cognitive…

  2. Journal Article

    Psychosocial and clinical determinants of medication adherence among elderly chronic disease patients in China

    Yujie Zhang; Yongli Han; Aning Sun et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    BackgroundIdentifying psychosocial factors associated with medication adherence is critical to optimize chronic disease management in elderly patients. This study aimed to explore key psychosocial and clinical determinants of medication adherence and their synergistic interactions among…

  3. Journal Article

    Curcumin protects high glucose-induced diabetic myocardial injury by regulating Nrf2 and PI3K/AKT pathways

    ZeYue Xu; ZhuangYin Qu; Xia Wu

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    Hyperglycemia can lead to excessive production of reactive oxygen species (ROS), contributing to diabetes and its complications, such as diabetic cardiomyopathy (DCM). This study aims to elucidate the protective mechanisms of Curcumin (CUR) against hyperglycemia-induced cardiomyocyte injury. We…

  4. Journal Article

    Analysis of the interaction network relationship between drugs using a graph neural network

    Zhongyi Chai; Jing Wang; Huili Du

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    IntroductionThe ever-increasing complexity of biochemical systems, alongside the rapid growth of pharmaceutical and biomedical data, underscores the urgent need for intelligent, scalable, and interpretable computational models. These models must be capable of supporting next-generation…

  5. Journal Article

    Microbiota-miR-101 interactions in obesity-associated colorectal cancer: from barrier dysfunction to precision therapeutic strategies

    Sidharth Prasad Mishra; Richard Jacobson; Bo Wang et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality worldwide, with obesity recognized as a major modifiable risk factor. Obesity-associated CRC is characterized by systemic low-grade inflammation, altered lipid metabolism, and gut microbial dysbiosis, all of…

  6. Journal Article

    Pharmacological safety and real-world efficacy of the potassium-competitive acid blocker fexuprazan in cardiovascular patients receiving antithrombotic therapy: a prospective cohort study (FEXGARD)

    You Mi Hwang; Sung Jung Kim; Myungjae Yoo

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    Background and AimsGastroesophageal reflux disease (GERD) is common in patients with CVD receiving long-term antithrombotic therapy, increasing gastrointestinal (GI) bleeding risk. Potassium-competitive acid blockers, such as fexuprazan, provide rapid and potent acid suppression; however, relevant…

  7. Journal Article

    Japanese evidence on Janus kinase inhibitors for rheumatoid arthritis: a narrative review of risk-optimized use

    Haruki Matsumoto; Shuhei Yoshida; Mako Tahara et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    BackgroundJanus kinase inhibitors (JAKi) have expanded treatment options for rheumatoid arthritis (RA) by providing rapid and effective oral therapy. However, their optimal use has become increasingly complex after the emergence of safety concerns involving serious infections, herpes zoster (HZ)…

  8. Journal Article

    The relevance of phenotypic definition in treatment resistant forms of major depressive disorder: a narrative review

    Pasquale Paribello; Ulker Isayeva; Silvia Lazzardi et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    Treatment-resistant depression (TRD) represents a major clinical and public health challenge contributing disproportionately to disability, healthcare utilisation, and societal costs. Progress in the field may be hindered by substantial heterogeneity in TRD phenotypic definitions and…

  9. Journal Article

    The efficacy of ultrasonic ablation combined with medication in the treatment of adenomyosis: a systematic review and network meta-analysis

    Qi Qin; Ruiqi Wang; Yu Yao et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    BackgroundAdenomyosis occurs when tissue from the inner lining of the endometrium grows into the muscle wall of the myometrium. Previous studies have suggested that High-Intensity Focused Ultrasound (HIFU) combined with medications may improve treatment outcomes for adenomyosis; however, the…

  10. Journal Article

    Tripterygium wilfordii Hook F accelerates CD4+ T-cell recovery in ART-treated people living with HIV with incomplete immune reconstitution: a longitudinal cohort study

    Liyuan Zheng; Fada Wang; Xiaojing Song et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    BackgroundIncomplete immune reconstitution (INR) affects 9%–45% of ART-treated people living with HIV (PLWH) and is associated with increased morbidity and mortality. Chronic immune activation and inflammatory signaling, particularly via the IP-10/CXCL10 pathway, are central to its pathogenesis…

  11. Journal Article

    Intelligent CpG nanoplatforms for targeted cancer immunotherapy and immune remodeling

    Huixia Wang; Yangming Zhang; Mengjiao Zhou

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    CpG oligonucleotides are potent immunoadjuvants that hold great promise for cancer immunotherapy, but their clinical use is limited by in vivo instability, off-target toxicity, and poor tumor targeting. Intelligent nanoplatforms offer effective solutions to these challenges by protecting CpG…

  12. Journal Article

    Metal-based nanomaterials for cancer phototherapy: current advancements and translational challenges

    Hao Su; Xinyu Zhao; Wenchao Xu et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    Cancer remains a leading global health challenge, with limitations in chemotherapy, radiotherapy, and immunotherapy driving interest in alternative modalities. Phototherapy, comprising photodynamic therapy and photothermal therapy, has shown promising antitumor efficacy, yet conventional…

  13. Journal Article

    Efficacy and safety of combining commercial Chinese polyherbal preparation with conventional medicine in the treatment of coronary microvascular disease: a systematic review and network meta-analysis

    Xiaoying Guo; Qianrong Li; Hugang Jiang et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    ObjectiveTo systematically assess and compare the efficacy and safety of 19 commercial Chinese polyherbal preparation for coronary microvascular disease (CMVD) through a frequentist network meta-analysis (NMA) of randomized controlled trials.MethodsA comprehensive search was performed across…

  14. Journal Article

    Post-marketing safety evaluation of mirogabalin using the JADER database

    Xinjuan Sun; Liyi Li; Gai Li et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    BackgroundMirogabalin, a novel third-generation α2-δ calcium channel ligand, is approved for diabetic peripheral neuropathic pain (DPNP). However, its post-marketing safety profile remains insufficiently characterized, particularly regarding novel signals and comparative safety profiles with…

  15. Journal Article

    The impact of China’s drug regulatory reform on access to orphan drugs: a cross-sectional study of diseases listed in the rare disease catalog

    Yipeng Lan; Xiaofeng Lin; Zhe Huang et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    ObjectiveChina released two batches of the Rare Disease Catalog in 2018 and 2023, respectively, listing a total of 207 diseases. This study aims to analyze the accessibility of medications for diseases included in the catalog and assess the impact of drug regulatory reforms on the supply of…

  16. Journal Article

    Polygonatum sibiricum combined with Poria cocos prevents spleen deficiency constipation via the gut microbiota–mediated brain–gut axis

    Menghui She; Xianqing Sun; Zhoujin Tan

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    IntroductionThe study evaluates the preventive effects of Polygonatum sibiricum and Poria cocos (3:1) on spleen deficiency constipation in mice, focusing on the brain-gut axis, gut microbiota, and oxidative stress. The findings aim to inform the prevention and treatment of this…

  17. Journal Article

    Research progress of artificial intelligence in high-throughput drug screening

    Xiaoyong Liu; Xiaoli Ren; Pengxi Li et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    High-throughput screening (HTS) is widely used in modern drug discovery. It enables batch activity testing of compounds and provides important support for the identification of active compounds. However, its screening efficiency and accuracy need to be improved. To address this issue, artificial…

  18. Journal Article

    Integrating CRISPR functional genomics with admixture-aware psychotropic pharmacogenetics in Brazil

    Brenda Bassan Rodrigues; Jasmine Coura Bittencourt; Vitória Gorga Machado dos Santos et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    Variability in the clinical response to psychotropic drugs remains a major barrier to effective psychiatric care. Pharmacogenetics offers a powerful framework for individualizing antidepressant and antipsychotic therapy, yet its implementation is complicated in genetically diverse populations. In…

  19. Journal Article

    Targeting STAT3 in systemic lupus erythematosus and lupus nephritis: mechanisms, therapeutic advances, and structure-informed perspectives

    Fangyu Yi; Xiao Tu; Ruxi Jin et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    This review summarizes the mechanistic and therapeutic relevance of Signal Transducer and Activator of Transcription 3 (STAT3) in systemic lupus erythematosus (SLE) and lupus nephritis (LN), with an emphasis on how structural information can inform drug development. STAT3 integrates cytokine- and…

  20. Journal Article

    Targeting the JAK/STAT pathway with isoliquiritigenin in ovarian cancer: molecular mechanisms and therapeutic implications

    Meidan Ding; Fangfang Guo; Ping Lin

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    Ovarian cancer, one of the most common gynecological malignancies, ranks as the fifth leading cause of cancer death in women. To investigate the mechanism by which isoliquiritigenin (ISL) regulates the JAK/STAT signaling pathway in ovarian cancer intervention, this review integrates cellular…

Showing at most 50 pages. Narrow your search with filters for more specific results.